| Niraparib |
尼拉帕尼 |
1038915-60-4 |
| GSK1120212 (DMSO solvate) |
曲美替尼二甲亚砜 |
1187431-43-1 |
| AZD2461 |
4-[4-氟-3-[(4-甲氧基哌啶-1-基)羰基]苄基]酞嗪-1(2H)-酮 |
1174043-16-3 |
| A66 |
A66 |
1166227-08-2 |
| b-AP15 |
b-AP15 |
1009817-63-3 |
| 5'-O-[(4-Cyanophenyl)methyl]-8-[[(3,4-dichlorophenyl)methyl]amino]-adenosine |
VER 155008 |
1134156-31-2 |
| exo-IWR 1 |
exo-IWR 1 |
1127442-87-8 |
| IM-12 |
IM-12 |
1129669-05-1 |
| CMP-NAN SODIUM SALT |
CMP-NAN SODIUM SALT |
1007117-62-5 |
| LDN-193189 |
LDN-193189 |
1062368-24-4 |
| 5-[6-(4-Methoxyphenyl)pyrazolo[1,5-a] |
(ML347) |
1062368-49-3 |
| C75 |
反-4-羧基-5-辛基-3-甲基-丁内酯 |
191282-48-1 |
| 3-PYRIDINECARBOXAMIDE, 6-(3-FLUOROPHENYL)-N-[1-(2,2,2-TRIFLUOROETHYL)-4-PIPERIDINYL]- |
6-(3-氟苯基)-N-[1-(2,2,2-三氟乙基)-4-哌啶基]-3-吡啶羧酰胺 |
1033836-12-2 |
| GNF 5837 |
GNF 5837 |
1033769-28-6 |
| DMA |
DMA |
188860-26-6 |
| Ceritinib (LDK378) |
色瑞替尼 |
1032900-25-6 |
| IGF-1R Inhibitor II, N-(5-Chloro-2-methoxyphenyl)-Nμ-(2-methylquinolin-4-yl)urea |
PQ 401 |
196868-63-0 |
| IC 261 |
3-(2,4,6-三甲氧基苯亚甲基)吲哚啉-2-酮 |
186611-52-9 |
| Valdecoxib |
代他考昔 |
181695-72-7 |
| DC-CHOL |
O-[(N,N-二甲基氨基乙基)-氨基甲酰基]胆固醇盐酸盐 |
166023-21-8 |
QQ
微信
